ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ATHX Athersys Inc

0.1018
0.00 (0.00%)
After Hours
Last Updated: 19:00:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Athersys Inc ATHX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.1018 19:00:00
Open Price Low Price High Price Close Price Prev Close
0.1018 0.1018
more quote information »

Recent News

Date Time Source Heading
1/08/202407:31EDGAR2Form 8-K - Current report
12/22/202317:09EDGAR2Form 8-K - Current report
12/21/202311:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202308:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/18/202308:00EDGAR2Form 8-K - Current report
10/16/202316:52BWAthersys Extends Near Term Liquidity with Proceeds from..
10/12/202309:28EDGAR2Form 8-K - Current report
10/11/202309:27EDGAR2Form 8-K - Current report
10/10/202308:30BWAthersys Reports Interim Analysis Results of MASTERS-2..
10/06/202317:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/06/202317:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202316:41EDGAR2Form 8-K - Current report
10/03/202316:30BWAthersys Licenses its Animal Health Assets to Ardent Animal..
10/02/202317:05EDGAR2Form 8-K - Current report
10/02/202317:04BWAthersys Director Jane Wasman Appointed Board Chair
9/25/202316:36EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
9/22/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
9/19/202312:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/18/202321:35EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
9/18/202321:04EDGAR2Form 8-K - Current report
9/14/202311:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/14/202310:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
9/13/202317:13EDGAR2Form S-3 - Registration statement under Securities Act of..
9/11/202308:46EDGAR2Form 8-K - Current report
9/06/202314:45BWGrant Awarded to Newcastle University to Research Athersys’..
8/21/202314:36EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
8/18/202310:14EDGAR2Form 8-K - Current report
8/17/202321:30BWAthersys, Inc. Announces Pricing of $3.5 Million Public..
8/17/202316:15EDGAR2Form DEF 14A - Other definitive proxy statements
8/16/202317:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/16/202317:01BWAthersys Reports Second Quarter 2023 Financial Results and..
8/11/202308:19EDGAR2Form 8-K - Current report
8/11/202308:00BWAthersys Appoints Neema Mayhugh, PhD to its Board of..
8/10/202317:03EDGAR2Form 8-K - Current report
8/08/202308:02EDGAR2Form 8-K - Current report
8/07/202317:02EDGAR2Form S-1/A - General form for registration of securities..
7/31/202313:38BWAthersys to Host Business Update Conference Call on August..
7/31/202308:01EDGAR2Form 8-K - Current report
7/26/202309:19EDGAR2Form S-1/A - General form for registration of securities..
7/14/202316:31EDGAR2Form S-1 - General form for registration of securities under..
7/14/202316:16EDGAR2Form 8-K/A - Current report: [Amend]
7/06/202309:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/06/202309:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/05/202314:04EDGAR2Form 8-K - Current report
6/01/202316:40BWPatient Enrollment Begins in Third and Final Cohort of the..
5/23/202308:30BWAthersys Restructures Debt with Supplier
5/18/202309:58BWAthersys Reports First Quarter 2023 Financial Results and..
5/08/202309:49BWAthersys to Participate in Three Upcoming Conferences
5/01/202308:30BWAthersys to Participate in The Cellular Therapies and..
4/21/202314:23BWAthersys to Participate in The American Society for Neural..

Your Recent History

Delayed Upgrade Clock